Systematic review on the efficacy and safety of herbal medicines for Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 14, Issue 2, 2008, Pages 209-223

  Man, Sui Cheung ^a   Durairajan, Siva Sundara Kumar ^a   Kum, Wan Fung ^a   Lu, Jia Hong ^a   Huang, Jian Dong ^b   Cheng, Ching Fung ^a   Chung, Vincent ^c   Xu, Min ^a   Li, Min ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Alzheimer's disease; Clinical trial; Herbal medicine; Systematic review

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; HERBACEOUS AGENT; MELISSA OFFICINALIS EXTRACT; NOOTROPIC AGENT; PLACEBO; SALVIA OFFICINALIS EXTRACT;

ABDOMINAL PAIN; AGITATION; ALZHEIMER DISEASE; ARTICLE; CELL HETEROGENEITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ETHNICITY; HERBAL MEDICINE; HUMAN; INTERVENTION STUDY; MONOTHERAPY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX RATIO; SIDE EFFECT; TREATMENT OUTCOME; VOMITING; WHEEZING;

EID: 47849090239     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2008-14209     Document Type: Article

References (117)

1. P.S. Aisen, Huperzine A in Alzheimer's Disease (Identifier: NCT00083590), http://clinicaltrials.gov/ct2/show/NCT00083590?cond= %22Alzheimer+Disease%22& rank=144, ClinicalTrials. gov, Last updated February 19, 2008, Accessed on March 11, 2008.
2. S. Akhondzadeh, M. Noroozian, M. Mohammadi, S. Ohadinia, A.H. Jamshidi and M. Khani, Melissa officinalis extract in the treatment of patients with mild to moderate alzheimer's disease: A double blind, randomised, placebo controlled trial, J Neurol Neurosurg Psychiatry 74 (2003), 863-866.
3. S. Akhondzadeh, M. Noroozian, M. Mohammadi, S. Ohadinia, A.H. Jamshidi and M. Khani, Salvia officinalis extract in the treatment of patients with mild to moderate alzheimer's disease: A double blind, randomized and placebo-controlled trial, J Clin Pharm Ther 28 (2003), 53-59.
4. D.G. Altman, K.F. Schulz, D. Moher, M. Egger, F. Davidoff, D. Elbourne, P.C. Gotzsche and T. Lang, The revised CONSORT statement for reporting randomized trials: Explanation and elaboration, Ann Intern Med 134 (2001), 663-694.
5. A History of Alzheimer's Disease, http://www.ahaf. org/alzdis/about/ adhistory.htm, Last reviewed on February 14, 2008, Accessed on March 11, 2008.
6. American Psychiatric Association, Work Group to Revise DSM-III, Diagnostic and Statistical Manual of Mental Disorders: DSM-III-R, American Psychiatric Association, Washington, DC, 1987.
7. American Psychiatric Association, Task Force on DSMIV, Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, American Psychiatric Association, Washington, DC, 1994.
8. L. Baum, A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease (Identifier: NCT00164749), ClinicalTrials. gov, http://clinicaltrials. gov/ct2/show/NCT00164749?cond=%22Alzheimer+Disease%22&rank=162, Last updated September 7, 2006, Accessed on December 30, 2007.
9. P. Bech, T.G. Bolwig, P. Kramp and O.J. Rafaelsen, The Bech-Rafaelsen mania scale and the hamilton depression scale, Acta Psychiatr Scand 59 (1979), 420-430.
10. A. Burns, E.J. Byrne and K. Maurer, Alzheimer's disease, Lancet 360 (2002), 163-165.
11. C.C. Chan and P.T. Lam, Update on dementia - part 1: Mild cognitive impairment, screening and diagnostic assessment, HK Pract 27 (2005), 235-241.
12. H. Chang and P.P. But, Pharmacology and Applications of Chinese Materia Medica, Volume II, World Scientific, Singapore, 1987.
13. Chinese Medical Association, Chinese Classification of Mental Disorders, Hunan Medical University, Hunan, China, 1990.
14. H.F. Chiu, L.C. Lam, I. Chi, T. Leung, S.W. Li, W.T. Law, D.W. Chung, H.H. Fung, P.S. Kan, C.M. Lum, J. Ng and J. Lau, Prevalence of dementia in Chinese elderly in Hong Kong, Neurology 50 (1998), 1002-1009.
15. J.L. Cummings, Alzheimer's disease, N Engl J Med 351 (2004), 56-67.
16. E. Dameron, Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease (Identifier: NCT00500500), ClinicalTrials.gov, http://clinicaltrials.gov/ct2/show/ NCT00500500?cond= %22Alzheimer+Disease%22&rank=115, Last updated July 11, 2007. Accessed December 30, 2007.
17. J. De Reuck and B. Van Vleymen, The clinical safety of high-dose piracetam - its use in the treatment of acute stroke, Pharmacopsychiatry 32 (1999), 33-37.
18. R. DeJong, O.W. Osterlund and G.W. Roy, Measurement of quality-of-life changes in patients with Alzheimer's disease, Clin Ther 11 (1989), 545-554.
19. S. Dharmananda, Alzheimer's Disease: Treatment with Chinese Herbs, http://www.itmonline.org/arts/alzheimers.htm, Last updated July 1996, Accessed March 11, 2008.
20. K.L. Dong and W.Y. Zeng, A summary on 20 cases of Alzheimer disease treated by yizhi jiannao granulea, Hunan J Tradit Chin Med 22 (2006), 3-4.
21. M.J. Engelhart, M.I. Geerlings, A. Ruitenberg, J.C. van Swieten, A. Hofman, J.C.M.Witteman and M.M.B. Breteler, Dietary intake of antioxidants and risk of Alzheimer disease, JAMA 287 (2002), 3223-3229.
22. E. Ernst and M.H. Pittler, Ginkgo biloba for dementia: A systematic review of double-blind, placebo-controlled trials, Clin Drug Invest 17 (1999), 301-308.
23. E. Esposito, D. Rotilio, V. Di Matteo, C. Di Giulio, M. Cacchio and S. Algeri, A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes, Neurobiol Aging 23 (2002), 719-735.
24. D.A. Evans, Prevalence of Alzheimer's disease, JAMA 264 (1990), 2996.
25. H. Fang and Z.D. Zhu, Clinical study on tong yu tang in the treatment of senile dementia [tong yu tang zhi liao nao nian xing chi dai de lin chuang yan jiu], J Shanxi Coll Tradit Chin Med 4 (2003), 27-28.
26. G.G. Fillenbaum and M.A. Smyer, The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire, J Gerontol 36 (1981), 428-434.
27. L. Flicker and G. Grimley Evans, Piracetam for dementia or cognitive impairment, Cochrane Database Syst Rev 1 (2001), CD001011.
28. M.F. Folstein, S.E. Folstein and P.R. McHugh, "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res 12 (1975), 189-198.
29. P.T. Francis, A.M. Palmer, M. Snape and G.K.Wilcock, The cholinergic hypothesis of alzheimer's disease: A review of progress, J Neurol Neurosurg Psychiatry 66 (1999), 137-147.
30. D.P. Gao, G.H. Chen and J. Yang, Investigation effect of naofuqing capsules on senile dementia 30 cases, Chin Tradit Patent Med 23 (2001), 263-265.
31. Y. Gong, L. Chang, K.L. Viola, P.N. Lacor, M.P. Lambert, C.E. Finch, G.A. Krafft and W.L. Klein, Alzheimer's disease-affected brain: Presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss, Proc Natl Acad Sci USA 100 (2003), 10417-10422.
32. E. Grassel, [Use of psychopathometric procedures in diagnosis of dementia exemplified by a comparison between the mini-mental state and the MWT/KAI (multiple-choice Vocabulary/General intelligence test short-form) test system], Z Gerontol 26 (1993), 268-274.
33. X.C. Guo, Clinical study on kang nao nian chi dai capsule in the treatment of senile dementia [kang nao nian chi dai jiao nang zhi liao lao nian qi chi dai lin chuang guan cha], Chin J Inf Tradit Chin Med 8 (2001), 68-69.
34. X.Z. Guo, H.C. Zhang, J.G. Cao, Y. Wang and J. Wang, Clinical study on treating dementia with combined traditional Chinese medicine and western medicine, Shanxi Med J 32 (2003), 425-427.
35. W. Guy, Clinical global impression (CGI), in: ECDEU Assessment Manual for Psychopharmacology, revised, W. Guy, ed., US Department of Health, Education, and Welfare, Rockville, 1976, pp. 218-222.
36. V.C. Hachinski, L.D. Iliff, E. Zilhka, G.H. Du Boulay, V.L. McAllister, J. Marshall, R.W. Russell and L. Symon, Cerebral blood flow in dementia, Arch Neurol 32 (1975), 632-637.
37. B.B. Han, X.F.Yang and Q.J. Li, Clinic investigation of treating senile dementia by traditional Chinese medicine, Chin J Pract Chin Mod Med 19 (2006), 658-659.
38. B. Hofferberth, The efficacy of EGb 761 in patients with senile dementia of the Alzheimer type, a double-blind, placebo-controlled study on different levels of investigation, Human Psychopharmacology 9 (1994), 215-222.
39. M.J. Howes, N.S. Perry and P.J. Houghton, Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders, Phytother Res 17 (2003), 1-18.
40. K. Iwasaki, T. Satoh-Nakagawa, M. Maruyama, Y. Monma, M. Nemoto, N. Tomita, H. Tanji, H. Fujiwara, T. Seki, M. Fujii, H. Arai and H. Sasaki, A randomized, observer-blind, controlled trial of the traditional Chinese medicine yi-gan san for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients, J Clin Psychiatry 66 (2005), 248-252.
41. A.R. Jadad, R.A. Moore, D. Carroll, C. Jenkinson, D.J. Reynolds, D.J. Gavaghan and H.J. McQuay, Assessing the quality of reports of randomized clinical trials: Is blinding necessary?, Control Clin Trials 17 (1996), 1-12.
42. M.C. Jia and W. Zhu, Clinical study on jian nao tang in the treatment of senile dementia [jian nao tang zhi liao lao nian chi dai zheng 31 li], Chin J Basic Med Tradit Chin Med 11 (2005), 312-313.
43. S. Kanowski and R. Hoerr, Ginkgo biloba extract EGb 761 in dementia: Intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial, Pharmacopsychiatry 36 (2003), 297-303.
44. S. Katz, Activities of daily living scale -"English", Home Health Care Serv Q 25(1/2) (2006), 13-31.
45. D. Kenner and Y. Requena, Botanical Medicine: A European Professional Perspective, Paradigm, Brookline, USA, 1996.
46. L.L. Kjaergard, J. Villumsen and C. Gluud, Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses, Ann Intern Med 135 (2001), 982-989.
47. V. Klusa, S. Germane, M. Noldner and S.S. Chatterjee, Hypericum extract and hyperforin: Memory-enhancing properties in rodents, Pharmacopsychiatry 34 (2001), S61-S69.
48. Z. Kmietowicz, NICE proposes to withdraw Alzheimer's drugs from NHS, BMJ 330 (2005), 495.
49. G.J. Larrabee, Further cautions in interpretation of comparisons between the WAIS-R and the wechsler memory scale, J Clin Exp Neuropsychol 9 (1987), 456-460.
50. P.L. Le Bars, M. Kieser and K.Z. Itil, A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia, Dement Geriatr Cogn Disord 11 (2000), 230-237.
51. H. Lehfeld and H. Erzigkeit, The SKT - a short cognitive performance test for assessing deficits of memory and attention, Int Psychogeriatr 9 (1997), 115-121.
52. B.G. Li, Treating Alzheimer's disease with Chinese herbal medicine and acupuncture [zhen yao he yong zhi liao nao nian xing chi dai 207 li], Forum Tradit Chin Med 21 (2006), 29.
53. H. Li, C.H. Wang and L. Wang, Clinical study on nao fu yi cong jiao nang in the treatment of senile dementia [nao fu yi cong jiao nang zhi liao nao lian xing chi dai de lin chuang guan cha], Chin J Inf Tradit Chin Med 9 (2002), 20-22.
54. J.M. Li, F.L. Chen and G.L. Li, A TCM approach to Alzheimer's disease [kai qiao xing nao tong luo fa zhi liao nao nian chi dai zheng 25 li], New J Tradit Chin Med 38 (2006), 71-72.
55. Q.M. Li, Q.H. Huang and Z.H. Tan, Clinical and experimental studies on naohuandan for senile dementia, Chin J Clin Rehab 8 (2004), 767-769.
56. X.H. Li and P. Gao, Cong min tang in the treatment of Alzheimer's disease [cong min tang zhi liao nao nian chi dai 30 li], Shaanxi J Tradit Chin Med 27 (2006), 544-545.
57. X.Y. Li, G.H. Lu, E. Gao, Y.L. Wang and S.R. Guo, Clinical study on hao shou fu zhi wan in the treatment of senile dementia [hao shou fu zhi wan zhi liao nao lian xing chi dai bing ji yi zhang ai 12 li lin chuang guan cha], New J Tradit Chin Med 32 (2000), 57-58.
58. F.M. Ling, G.M. Lu, J.L. Chen and M. Gao, Clinical study on nao ling ke li in the treatment of senile dementia [nao ling ke li zhi liao lao nian qi chi dai 38 li lin chuang guan cha], Chin J Tradit Med Sci Technol 10 (2003), 182-184.
59. X.Z. Lu, X.L. Wang, Y. Lin and S.M. Li, Clinical observation of anti-dementia I on senile brain dysfunction, Tianjin J Tradit Chin Med 19 (2002), 13-15.
60. B.V. Manyam, Dementia in ayurveda, J Altern Complement Med 5 (1999), 81-88.
61. B.B. Mao, Yi shen jian nao tang in the treatment of alzheimer' disease [yi shen jian nao tang zhi liao nao nian xing chi dai lin chuang ti hui], Chin Mag Clin Med Prof Res 12 (2006), 2521-2522.
62. M. Maruyama, N. Tomita, K. Iwasaki, M. Ootsuki, T. Matsui, M. Nemoto, N. Okamura, M. Higuchi, M. Tsutsui, T. Suzuki, T. Seki, T. Kaneta, K. Furukawa and H. Arai, Benefits of combining donepezil plus traditional Japanese herbal medicine on cognition and brain perfusion in Alzheimer's disease: A 12-week observer-blind, donepezil monotherapy controlled trial, J Am Geriatr Soc 54 (2006), 869-871.
63. M.K. Matthews Jr., Association of ginkgo biloba with intracerebral hemorrhage, Neurology 50 (1998), 1933-1934.
64. K. Maurer, R. Ihl, T. Dierks and L. Frolich, Clinical efficacy of ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type, J Psychiatr Res 31 (1997), 645-655.
65. M. Mazza, A. Capuano, P. Bria and S. Mazza, Ginkgo biloba and donepezil: Acomparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study, Eur J Neurol 13 (2006), 981-985.
66. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price and E.M. Stadlan, Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology 34 (1984), 939-944.
67. X.Z. Meng, Y.L. Zhang, J.Y. Wang and L. Yang, Clinical study on qing nao fang in the treatment of senile dementia [qing nao fang zhi liao nao lian xing chi dai zheng 56 li lin chuang guan cha], Chin J Tradit Med Sci Technol 9 (2002), 120.
68. X.Z. Meng and Y.X. Ye, Clinical study on shun qi dao tan tang in the treatment of senile dementia [shun qi dao tan tang zhi liao lao nian xing chi dai 36 li lin chuang guan cha], Med J Ind Enterp 16 (2003), 60-61.
69. E.R. Miller 3rd, R. Pastor-Barriuso, D. Dalal, R.A. Riemersma, L.J. Appel and E. Guallar, Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality, Ann Intern Med 142 (2005), 37-46.
70. D. Moher, K.F. Schulz and D. Altman, The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials, JAMA 285 (2001), 1987-1991.
71. R.C. Mohs, W.G. Rosen and K.L. Davis, The Alzheimer's disease assessment scale: An instrument for assessing treatment efficacy, Psychopharmacol Bull 19 (1983), 448-450.
72. R.C. Mohs and L. Cohen, Alzheimer's disease assessment scale (ADAS). Psychopharmacol Bull 24 (1988), 627-628.
73. A.H. Moore and M.K. O'Banion, Neuroinflammation and anti-inflammatory therapy for Alzheimer's disease, Adv Drug Deliv Rev 54 (2002), 1627-1656.
74. J.C. Morris, The clinical dementia rating (CDR): Current version and scoring rules, Neurology 43 (1993), 2412-2414.
75. J.C. Morris, A. Heyman, R.C. Mohs, J.P. Hughes, G. van Belle, G. Fillenbaum, E.D. Mellits and C. Clark, The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), Part I. Clinical and neuropsychological assessment of Alzheimer's disease, Neurology 39 (1989), 1159-1165.
76. Z.X. Mu and X.Y. Li, Clinical study on Chinese herbal decoction chong nao tang in the treatment of senile dementia [zhong yao chong nao tang zhi liao lao nian xing chi dai de lin chuang yan jiu], J Shanxi Coll Tradit Chin Med 5 (2004), 23-25.
77. O. Napryeyenko, I. Borzenko and G. GINDEM-NP Study, Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial, Arzneimittelforschung 57 (2007), 4-11.
78. N.W. Nelson, Differential diagnosis of Alzheimer's dementia and vascular dementia, Dis Mon 53 (2007), 148-151.
79. A. Nordberg, Pharmacological treatment of cognitive dysfunction in dementia disorders, Acta Neurol Scand Suppl 168 (1996), 87-92.
80. F. Oakley, J.S. Lai and T. Sunderland, A validation study of the daily activities questionnaire: An activities of daily living assessment for people with Alzheimer's disease, J Outcome Meas 3 (1999), 297-307.
81. M. Oremus, C. Wolfson, A. Perrault, L. Demers, F. Momoli and Y. Moride, Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials. Dement Geriatr Cogn Disord 12 (2001), 232-236.
82. M.K. Oride, J.K. Marutani, M.W. Rouse and P.N. DeLand, Reliability study of the Pierce and King-Devick saccade tests, Am J Optom Physiol Opt 63 (1986), 419-424.
83. W.D. Oswald, [Psychometric procedures and questionnaires in geronto-psychological research], Z Gerontol 12 (1979), 341-350.
84. N. Perry, G. Court, N. Bidet, J. Court and E. Perry, European herbs with cholinergic activities: Potential in dementia therapy, Int J Geriatr Psychiatry 11 (1996), 1063-1069.
85. G. Perusini, The nosographic value of some characteristic histopathologic findings in senility, Riv Ital Neuropathol Psichiatr Elettroterapia 4 (1911), 193-213.
86. X.F. Qiu, P. Wang, Y.N. Wu, L.T. Zhang and D.P. Yuan, Clinical study on xing nao yi zhi chong ji in the treatment of senile dementia [xing nao yi zhi chong ji zhi liao lao nian xing chi dai lin chuang yan jiu], Hubei J Tradit Chin Med 27 (2005), 3-5.
87. J. Quinn, J. Kaye, T. Montine and R. Stackman, Phytochemicals in Alzheimer disease: The development of clinical trials, Pharm Biol 42 (2004), 64-73.
88. B. Reisberg, S.H. Ferris, Brief cognitive rating scale (BCRS), Psychopharmacol Bull 24 (1988), 629-636.
89. J.M. Ringman, Curcumin in Patients With Mild to Moderate Alzheimer's Disease (Identifier: NCT00099710), http://clinicaltrials.gov/ct2/show/ NCT00099710?cond=% 22Alzheimer+Disease%22,ClinicalTrials.gov, Last updated February 28, 2008, Accessed March 11, 2008.
90. J.M. Ringman, S.A. Frautschy, G.M. Cole, D.L. Masterman and J.L. Cummings, A potential role of the curry spice curcumin in Alzheimer's disease, Curr Alzheimer Res 2 (2005), 131-136.
91. J. Rowin and S.L. Lewis, Spontaneous bilateral subdural hematomas associated with chronic ginkgo biloba ingestion, Neurology 46 (1996), 1775-1776.
92. M.K. Samanta, B. Wilson, K. Santhi, K.P.S. Kumar and B. Suresh, Alzheimer disease and its management: A review, Am J Ther 43 (2006), 516-526.
93. L.S. Schneider, J.T. Olin, R.S. Doody, C.M. Clark, J.C. Morris, B. Reisberg, F.A. Schmitt, M. Grundman, R.G. Thomas and S.H. Ferris, Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study, Alzheimer Dis Assoc Disord 11 (1997), S22-S32.
94. L.S. Schneider, S.T. DeKosky, M.R. Farlow, P.N. Tariot, R. Hoerr and M. Kieser, A randomized, double-blind, placebo-controlled trial of two doses of ginkgo biloba extract in dementia of the Alzheimer's type, Curr Alzheimer Res 2 (2005), 541-551.
95. V. Schulz, R. Hänsel and V.E. Tyler, Rational Phytotherapy: A Physicians' Guide to Herbal Medicine, Springer-Verlag, New York, 1998.
96. K.F. Schulz and D.A. Grimes, Sample size slippages in randomised trials: Exclusions and the lost and wayward, Lancet 359 (2002), 781-785.
97. K.F. Schulz and D.A. Grimes, Sample size calculations in randomised trials: Mandatory and mystical, Lancet 365 (2005), 1348-1353.
98. G.E. Schwartz, Geriatric evaluation by relative's rating instrument (GERRI), Psychopharmacol Bull 24 (1988), 713-716.
99. D.J. Selkoe, The origins of Alzheimer disease, JAMA 283 (2000), 1615-1617.
100. R.I. Shader, J.S. Harmatz and C. Salzman, A new scale for clinical assessment in geriatric populations: Sandoz Clinical Assessment-Geriatric (SCAG). J Am Geriatr Soc 22 (1974), 107-113.
101. Z.G. Shi, X.H. Zhang, Y.H. Liu, H.Y. Qu and X.R. Li, The capsule of fu yuan treat old-age dementia 150 example of clinical research, Chin J Pract Chin Mod Med 18 (2005), 1488-1490.
102. G.W. Small, P.V. Rabins, P.P. Barry, N.S. Buckholtz, S.T. DeKosky, S.H. Ferris, S.I. Finkel, L.P. Gwyther, Z.S. Khachaturian, B.D. Lebowitz, T.D. McRae, J.C. Morris, F. Oakley, L.S. Schneider, J.E. Streim, T. Sunderland, L.A. Teri and L.E.Tune, Diagnosis and treatment of Alzheimer disease and related disorders. Consensus Statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society, JAMA 278 (1997), 1363-1371.
103. M.G. Spillantini and M. Goedert, Tau protein pathology in neurodegenerative diseases, Trends Neurosci 21 (1998), 428-433.
104. T. Suzuki, S. Futami, Y. Igari, N. Matsumura, K. Watanabe, H. Nakano, K. Oba, Y. Murata, H. Koibuchi and Y. Kigawa, A Chinese herbal medicine, choto-san, improves cognitive function and activities of daily living of patients with dementia: A double-blind, randomized, placebo-controlled study, J Am Geriatr Soc 53 (2005), 2238-2240.
105. What is Alzheimer's - introduction, http://www.alz. org/ alzheimers_disease_what_is_alzheimers.asp, Last updated November 21, 2007. Accessed March 11, 2008.
106. N. Tsai and Z.X. Gao, Validity of Hasegawa's dementia scale for screening dementia among aged Chinese, Int Psychogeriatr 1 (1989), 145-152.
107. R. Upton, Ashwagandha root. withania somnifera. analytical, quality control and therapeutic monograph. in: American Herbal Pharmacopoeia and Therapeutic Compendium, Anonymous, 2000, pp. 1-25.
108. Statistics by Country for Alzheimer's disease: Extrapolation of prevalence rate of Alzheimer's disease to countries and regions, http://www.wrongdiagnosis.com/a/alzheimers_ disease/stats-country.htm, Last updated February 4, 2008. Accessed March 11, 2008.
109. M. van Dongen, E. van Rossum, A. Kessels, H. Sielhorst and P. Knipschild, Ginkgo for elderly people with dementia and age-associated memory impairment: A randomized clinical trial, J Clin Epidemiol 56 (2003), 367-376.
110. M.C. van Dongen, E. van Rossum, A.G. Kessels, H.J. Sielhorst and P.G. Knipschild, The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: New results of a randomized clinical trial, J Am Geriatr Soc 48 (2000), 1183-1194.
111. H. Wang, X. Yu, S. Li, Y. Chen, H. Li and J. He, The cognitive subscale of Alzheimer's disease assessment scale, Chinese version in staging of Alzheimer disease, Alzheimer Dis Assoc Disord 18 (2004), 231-235.
112. World Health Organization, The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines, World Health Organization, Geneva, 1992.
113. G.L. Yan, Clinical study on sheng nao chong ji in the treatment of senile dementia [sheng nao chong ji zhi liao lao nian qi chi dai de lin chuang yan jiu], New J Tradit Chin Med 33 (2001), 71-72.
114. E. Yarnell, Lemonbalm: Humble but potent herb. Altern Complement Ther 4 (1998), 417-419.
115. B. Yoon, D.K. Kim, Y. Kang, J. Kim, M. Shin and D.L. Na, Hormone replacement therapy in postmenopausal women with Alzheimer's disease: A randomized, prospective study, Fertil Steril 79 (2003), 274-280.
116. X.L. Yu, Clinical observation on the treatment of 42 cases of senile dementia with the method of tonifying kidney and activating blood and dissipating phlegm, Guiding J TCM 12 (2006), 24-25.
117. W. Zhang, T. Leonard, F. Bath-Hextall, C.A. Chambers, C. Lee, R. Humphreys and H.C. Williams, Chinese herbal medicine for atopic eczema. Cochrane Database Syst Rev 4 (2004), CD002291.